541 related articles for article (PubMed ID: 15041222)
1. Analysis of human papillomavirus prevalence and TP53 polymorphism in head and neck squamous cell carcinomas.
Cortezzi SS; Provazzi PJ; Sobrinho JS; Mann-Prado JC; Reis PM; de Freitas SE; Filho JF; Fukuyama EE; Cordeiro JA; Cury PM; Maniglia JV; Villa LL; Tajara EH; Rahal P
Cancer Genet Cytogenet; 2004 Apr; 150(1):44-9. PubMed ID: 15041222
[TBL] [Abstract][Full Text] [Related]
2. p53 codon 72 polymorphism associated with risk of human papillomavirus-associated squamous cell carcinoma of the oropharynx in never-smokers.
Ji X; Neumann AS; Sturgis EM; Adler-Storthz K; Dahlstrom KR; Schiller JT; Wei Q; Li G
Carcinogenesis; 2008 Apr; 29(4):875-9. PubMed ID: 18258602
[TBL] [Abstract][Full Text] [Related]
3. TP53 polymorphism, HPV infection, and risk of cervical cancer.
Klug SJ; Wilmotte R; Santos C; Almonte M; Herrero R; Guerrero I; Caceres E; Peixoto-Guimaraes D; Lenoir G; Hainaut P; Walboomers JM; Muñoz N
Cancer Epidemiol Biomarkers Prev; 2001 Sep; 10(9):1009-12. PubMed ID: 11535556
[TBL] [Abstract][Full Text] [Related]
4. p53 codon 72 polymorphic variants, loss of allele-specific transcription, and human papilloma virus 16 and/or 18 E6 messenger RNA expression in squamous cell carcinomas of the head and neck.
Scheckenbach K; Lieven O; Götte K; Bockmühl U; Zotz R; Bier H; Balz V
Cancer Epidemiol Biomarkers Prev; 2004 Nov; 13(11 Pt 1):1805-9. PubMed ID: 15533911
[TBL] [Abstract][Full Text] [Related]
5. Human papillomavirus and p53 polymorphism in codon 72 in head and neck squamous cell carcinoma.
Hoffmann M; Scheunemann D; Fazel A; Görögh T; Kahn T; Gottschlich S
Oncol Rep; 2009 Mar; 21(3):809-14. PubMed ID: 19212643
[TBL] [Abstract][Full Text] [Related]
6. [Correlation between P53 codon 72 polymorphism and tumorigenesis of cervical cancer].
Li CY; Liu JH; Huang BJ
Ai Zheng; 2004 Nov; 23(11 Suppl):1396-9. PubMed ID: 15566643
[TBL] [Abstract][Full Text] [Related]
7. Effect of human papillomavirus-16 infection on CD8+ T-cell recognition of a wild-type sequence p53264-272 peptide in patients with squamous cell carcinoma of the head and neck.
Sirianni N; Ha PK; Oelke M; Califano J; Gooding W; Westra W; Whiteside TL; Koch WM; Schneck JP; DeLeo A; Ferris RL
Clin Cancer Res; 2004 Oct; 10(20):6929-37. PubMed ID: 15501971
[TBL] [Abstract][Full Text] [Related]
8. Demographic and risk factors in patients with head and neck tumors.
Tachezy R; Klozar J; Rubenstein L; Smith E; Saláková M; Smahelová J; Ludvíková V; Rotnáglová E; Kodet R; Hamsíková E
J Med Virol; 2009 May; 81(5):878-87. PubMed ID: 19319944
[TBL] [Abstract][Full Text] [Related]
9. The p53 Arg72Pro polymorphism, human papillomavirus, and invasive squamous cell cervical cancer.
Madeleine MM; Shera K; Schwartz SM; Daling JR; Galloway DA; Wipf GC; Carter JJ; McKnight B; McDougall JK
Cancer Epidemiol Biomarkers Prev; 2000 Feb; 9(2):225-7. PubMed ID: 10698487
[TBL] [Abstract][Full Text] [Related]
10. p53 Codon 72 polymorphism, loss of heterozygosity and high-risk human papillomavirus infection in a low-incidence German esophageal squamous cell carcinoma patient cohort.
Pantelis A; Pantelis D; Ruemmele P; Hartmann A; Hofstaedter F; Buettner R; Bootz F; Stoehr R
Oncol Rep; 2007 May; 17(5):1243-8. PubMed ID: 17390072
[TBL] [Abstract][Full Text] [Related]
11. [Causal association between human papilloma virus infection and head and neck and esophageal squamous cell carcinoma].
Szentirmay Z; Szántó I; Bálint I; Pólus K; Remenár E; Tamás L; Szentkúti G; Melegh Z; Nagy P; Kásler M
Magy Onkol; 2002; 46(1):35-41. PubMed ID: 12050680
[TBL] [Abstract][Full Text] [Related]
12. Occurrence of p53 gene deletions and human papilloma virus infection in human head and neck cancer.
Brachman DG; Graves D; Vokes E; Beckett M; Haraf D; Montag A; Dunphy E; Mick R; Yandell D; Weichselbaum RR
Cancer Res; 1992 Sep; 52(17):4832-6. PubMed ID: 1324797
[TBL] [Abstract][Full Text] [Related]
13. p53 codon 72 polymorphisms in human papillomavirus-negative and human papillomavirus-positive squamous cell carcinomas of the oropharynx.
Perrone F; Mariani L; Pastore E; Orsenigo M; Suardi S; Marcomini B; DaRiva L; Licitra L; Carbone A; Pierotti MA; Pilotti S
Cancer; 2007 Jun; 109(12):2461-5. PubMed ID: 17492690
[TBL] [Abstract][Full Text] [Related]
14. Human papillomavirus and p53 mutational status as prognostic factors in head and neck carcinoma.
Sisk EA; Soltys SG; Zhu S; Fisher SG; Carey TE; Bradford CR
Head Neck; 2002 Sep; 24(9):841-9. PubMed ID: 12211048
[TBL] [Abstract][Full Text] [Related]
15. The prevalence of human papillomavirus in the oropharynx in healthy individuals in a Brazilian population.
do Sacramento PR; Babeto E; Colombo J; Cabral Ruback MJ; Bonilha JL; Fernandes AM; Pereira Sobrinho JS; de Souza FP; Villa LL; Rahal P
J Med Virol; 2006 May; 78(5):614-8. PubMed ID: 16555270
[TBL] [Abstract][Full Text] [Related]
16. Human papilloma virus and p53 in head and neck cancer: clinical correlates and survival.
Haraf DJ; Nodzenski E; Brachman D; Mick R; Montag A; Graves D; Vokes EE; Weichselbaum RR
Clin Cancer Res; 1996 Apr; 2(4):755-62. PubMed ID: 9816227
[TBL] [Abstract][Full Text] [Related]
17. Analysis of TP53 codon 72 polymorphism in HPV-positive and HPV-negative penile carcinoma.
Tornesello ML; Duraturo ML; Guida V; Losito S; Botti G; Pilotti S; Stefanon B; De Palo G; Buonaguro L; Buonaguro FM
Cancer Lett; 2008 Sep; 269(1):159-64. PubMed ID: 18513854
[TBL] [Abstract][Full Text] [Related]
18. No relationship observed between human p53 codon-72 genotype and HPV-associated cervical cancer in a population group with a low arginine-72 allele frequency.
Govan VA; Loubser S; Saleh D; Hoffman M; Williamson AL
Int J Immunogenet; 2007 Jun; 34(3):213-7. PubMed ID: 17504512
[TBL] [Abstract][Full Text] [Related]
19. An increased lung cancer risk associated with codon 72 polymorphism in the TP53 gene and human papillomavirus infection in Mazandaran province, Iran.
Nadji SA; Mahmoodi M; Ziaee AA; Naghshvar F; Torabizadeh J; Yahyapour Y; Nategh R; Mokhtari-Azad T
Lung Cancer; 2007 May; 56(2):145-51. PubMed ID: 17208332
[TBL] [Abstract][Full Text] [Related]
20. Human papillomavirus in head and neck carcinomas: prevalence, physical status and relationship with clinical/pathological parameters.
Badaracco G; Venuti A; Morello R; Muller A; Marcante ML
Anticancer Res; 2000; 20(2B):1301-5. PubMed ID: 10810439
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
